Abstract

Background Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer related death in the U.S, has a 5-year survival rate of only 10%.1 The paucity of T cells in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
748 Targeting vasoactive intestinal peptide receptor signaling in pancreatic ductal adenocarcinoma for enhanced anti-tumor response to checkpoint blockade
...
Journal for ImmunoTherapy of Cancer | VOL. 9
, et. al. ...
01 Nov 2021
310 Engineering optimal CAR T cells to overcome pancreatic tumors with secreted antagonistic peptides
Alysa Evans ... Edmund Waller
Journal for ImmunoTherapy of Cancer | VOL. 10
Alysa Evans, et. al.Alysa Evans ... Edmund Waller
01 Nov 2022
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: Antagonistic action of a growth-hormone-releasing hormone analog
Andrew Schally ... Antonio Ruíz-Villaespesa
International Journal of Oncology | VOL. 26
Andrew Schally, et. al.Andrew Schally ... Antonio Ruíz-Villaespesa
01 Jun 2005
Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours.
Harald Meinhold ... Michael Böhmig
European journal of nuclear medicine | VOL. 27
Harald Meinhold, et. al.Harald Meinhold ... Michael Böhmig
19 Aug 2000
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma
Sofie Kirial Mørk ... Inge Marie Svane
Journal for ImmunoTherapy of Cancer | VOL. 12
Sofie Kirial Mørk, et. al.Sofie Kirial Mørk ... Inge Marie Svane
23 May 2024
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade
Chilam Chan ... Jeanette Leusen
Journal for ImmunoTherapy of Cancer | VOL. 12
Chilam Chan, et. al.Chilam Chan ... Jeanette Leusen
23 May 2024
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
Lorenzo Gervaso ... Nicola Fazio
Journal for ImmunoTherapy of Cancer | VOL. 12
Lorenzo Gervaso, et. al.Lorenzo Gervaso ... Nicola Fazio
23 May 2024
Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
Zhenqiang Sun ... Junhong Hu
Journal for ImmunoTherapy of Cancer | VOL. 12
Zhenqiang Sun, et. al.Zhenqiang Sun ... Junhong Hu
23 May 2024
View more papers